1-4 of 4
maturity onset diabetes mellitus in young
Close
Sort by
Journal Articles

Association of Inpatient Opioid Utilization and Readmission Risk in Sickle Cell Disease

Jin Han, PharmD, PhD, Santosh L. Saraf, MD, Michel Gowhari, DO, Shivi Jain, MD, Robert E. Molokie, MD, Victor R. Gordeuk, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4699.
https://doi.org/10.1182/blood-2018-99-114733
Published: 2018
Journal Articles

Program Expansion of a Day Hospital Dedicated to Manage Sickle Cell Pain

Jin Han, PharmD, PhD, Laura Kavoliunaite, APN, Santosh L. Saraf, MD, Shivi Jain, MD, Johara Hassan, MD, Lewis L Hsu, MD PhD, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Michel Gowhari, DO
Journal: Blood
Blood (2017) 130 (Supplement 1): 4664.
https://doi.org/10.1182/blood.V130.Suppl_1.4664.4664
Published: 2017
Journal Articles

Efficacy and Safety of Hematopoietic Stem Cell Remobilization with Plerixafor (Mozobil ® ) + G-CSF In Adult Patients with Non-Hematologic Malignancies

Mitchell E. Horwitz, MD, Edward Gorak, Peter Holman, MD, Edward Libby, MD, Dirk Huebner, MD, Purvi D Mody, PhD, Jeffrey R. Schriber, MD
Journal: Blood
Blood (2010) 116 (21): 2249.
https://doi.org/10.1182/blood.V116.21.2249.2249
Published: 2010
Journal Articles

Plerixafor (Mozobil ® )Plus G-CSF Is Effective in Mobilizing Hematopoietic Stem Cells in Patients with Concurrent Thrombocytopenia Undergoing Autologous Hematopoietic Stem Cell Transplantation.

Ivana N Micallef, MD, Eric Jacobsen, Paul Shaughnessy, MD, Sachin Marulkar, MBBS, MPH, Purvi Mody, PhD, Frits van Rhee, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3229.
https://doi.org/10.1182/blood.V114.22.3229.3229
Published: 2009